Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer

Transformation to small cell lung cancer is irrespective of EGFR and accelerated by SMAD4-mediated ASCL1 transcription independently of RB1 in non-small cell lung cancer

Abstract Objectives Histological transformation to small cell lung cancer (SCLC) has been identified as a mechanism of TKIs resistance in EGFR-mutant non-small cell lung cancer (NSCLC). We aim to explore the prevalence of transformation in EGFR-wildtype NSCLC and the mechanism of SCLC transformation...

Olles dieđut

Bibliográfalaš dieđut
Váldodahkkit: Xi Ding, Min-xing Shi, Di Liu, Jing-xue Cao, Kai-xuan Zhang, Run-dong Zhang, Li-ping Zhang, Kai-xing Ai, Bo Su, Jie Zhang
Materiálatiipa: Artihkal
Giella:English
Almmustuhtton: BMC 2024-01-01
Ráidu:Cell Communication and Signaling
Fáttát:
SMAD4
Small-cell transformation
EGFR-TKI therapy
Drug resistance
Myc inhibitor
Liŋkkat:https://doi.org/10.1186/s12964-023-01260-8

Interneahtta

https://doi.org/10.1186/s12964-023-01260-8

Geahča maid